A detailed history of J.W. Cole Advisors, Inc. transactions in Organon & Co. stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 12,440 shares of OGN stock, worth $183,241. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,440
Previous 13,032 4.54%
Holding current value
$183,241
Previous $269,000 11.9%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$18.65 - $23.03 $11,040 - $13,633
-592 Reduced 4.54%
12,440 $237,000
Q2 2024

Aug 08, 2024

SELL
$17.45 - $21.96 $1,954 - $2,459
-112 Reduced 0.85%
13,032 $269,000
Q1 2024

Apr 30, 2024

BUY
$13.78 - $18.8 $1,667 - $2,274
121 Added 0.93%
13,144 $247,000
Q4 2023

Jan 31, 2024

BUY
$10.95 - $17.32 $142,601 - $225,558
13,023 New
13,023 $187,000
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $1.81 Million - $2.33 Million
59,286 New
59,286 $56,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track J.W. Cole Advisors, Inc. Portfolio

Follow J.W. Cole Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.